Target Price | $494.70 |
Price | $350.25 |
Potential |
41.24%
register free of charge
|
Number of Estimates | 22 |
22 Analysts have issued a price target Elevance Health 2026 .
The average Elevance Health target price is $494.70.
This is
41.24%
register free of charge
$614.25
75.37%
register free of charge
$432.28
23.42%
register free of charge
|
|
A rating was issued by 28 analysts: 20 Analysts recommend Elevance Health to buy, 8 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Elevance Health stock has an average upside potential 2026 of
41.24%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 176.81 | 196.60 |
3.19% | 11.19% | |
EBITDA Margin | 5.51% | 6.10% |
9.12% | 10.78% | |
Net Margin | 3.38% | 3.99% |
3.21% | 17.97% |
22 Analysts have issued a sales forecast Elevance Health 2025 . The average Elevance Health sales estimate is
This results in the following potential growth metrics:
15 Analysts have issued an Elevance Health EBITDA forecast 2025. The average Elevance Health EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
25 Elevance Health Analysts have issued a net profit forecast 2025. The average Elevance Health net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 25.68 | 34.75 |
1.82% | 35.32% | |
P/E | 11.39 | |
EV/Sales | 0.61 |
25 Analysts have issued a Elevance Health forecast for earnings per share. The average Elevance Health EPS is
This results in the following potential growth metrics and future valuations:
Elevance Health...
Analyst | Rating | Action | Date |
---|---|---|---|
Truist Securities |
Locked
➜
Locked
|
Locked | Jun 09 2025 |
RBC Capital |
Locked
➜
Locked
|
Locked | Jun 04 2025 |
Barclays |
Locked
➜
Locked
|
Locked | Jun 02 2025 |
Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Apr 23 2025 |
RBC Capital |
Locked
➜
Locked
|
Locked | Apr 23 2025 |
Guggenheim |
Locked
➜
Locked
|
Locked | Apr 23 2025 |
Barclays |
Locked
➜
Locked
|
Locked | Apr 23 2025 |
Analyst Rating | Date |
---|---|
Locked
Truist Securities:
Locked
➜
Locked
|
Jun 09 2025 |
Locked
RBC Capital:
Locked
➜
Locked
|
Jun 04 2025 |
Locked
Barclays:
Locked
➜
Locked
|
Jun 02 2025 |
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Apr 23 2025 |
Locked
RBC Capital:
Locked
➜
Locked
|
Apr 23 2025 |
Locked
Guggenheim:
Locked
➜
Locked
|
Apr 23 2025 |
Locked
Barclays:
Locked
➜
Locked
|
Apr 23 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.